Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

ReWalk Robotics logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Stock News Headlines

Lake Street Keeps Their Buy Rating on Rewalk Robotics (LFWD)
Lake Street Sticks to Its Buy Rating for Rewalk Robotics (LFWD)
Refund From 1933: Trump’s Reset May Create Instant Wealth
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.
ReWalk Robotics Ltd (2RW.MU)
ReWalk Robotics earnings: here's what Wall Street expects
See More Headlines

RWLK Stock Analysis - Frequently Asked Questions

ReWalk Robotics Ltd. (NASDAQ:RWLK) announced its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet (CLMT), Two Harbors Investments (TWO), NVIDIA (NVDA), Meta Platforms (META) and NovoCure (NVCR).

Company Calendar

Last Earnings
11/11/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
CIK
1607962
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.57 million
Net Margins
-238.35%
Pretax Margin
-233.51%
Return on Equity
-29.00%
Return on Assets
-25.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.47
Quick Ratio
2.99

Sales & Book Value

Annual Sales
$5.51 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
60,030,000
Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RWLK) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners